BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 35918133)

  • 1. Brief report on IQOS point-of-sale marketing, promotion and pricing in IQOS retail partner stores in Atlanta, Georgia, USA.
    Henderson KC; Van Do V; Wang Y; Duan Z; Popova L; Spears CA; Weaver SR; Ashley DL; Barker DC; Huang J
    Tob Control; 2023 Aug; 32(e2):e260-e264. PubMed ID: 35918133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of IQOS Marketing Strategies at Points-of-Sale in Israel at a Time of Regulatory Transition.
    Bar-Zeev Y; Berg CJ; Abroms LC; Rodnay M; Elbaz D; Khayat A; Levine H
    Nicotine Tob Res; 2022 Jan; 24(1):100-108. PubMed ID: 34216461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IQOS point-of-sale marketing strategies in Israel: a pilot study.
    Bar-Zeev Y; Levine H; Rubinstein G; Khateb I; Berg CJ
    Isr J Health Policy Res; 2019 Jan; 8(1):11. PubMed ID: 30642383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Marketing IQOS in a dark market.
    Mathers A; Schwartz R; O'Connor S; Fung M; Diemert L
    Tob Control; 2019 Mar; 28(2):237-238. PubMed ID: 29724866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Point-of-sale marketing of heated tobacco products in Israel: cause for concern.
    Halpern-Felsher B
    Isr J Health Policy Res; 2019 May; 8(1):47. PubMed ID: 31133053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IQOS marketing strategies at point-of-sales: a cross-sectional survey with retailers.
    Bar-Zeev Y; Berg CJ; Khayat A; Romm KF; Wysota CN; Abroms LC; Elbaz D; Levine H
    Tob Control; 2023 Aug; 32(e2):e198-e204. PubMed ID: 35140170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retail Marketing of Menthol Cigarettes in Los Angeles, California: a Challenge to Health Equity.
    Smiley SL; Cho J; Blackman KCA; Cruz TB; Pentz MA; Samet JM; Baezconde-Garbanati L
    Prev Chronic Dis; 2021 Feb; 18():E11. PubMed ID: 33571082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cigarette and E-Cigarette Retail Marketing on and Near California Tribal Lands.
    Begay C; Soto C; Baezconde-Garbanati L; Barahona R; Rodriguez YL; Unger JB; Smiley SL
    Health Promot Pract; 2020 Jan; 21(1_suppl):18S-26S. PubMed ID: 31908191
    [No Abstract]   [Full Text] [Related]  

  • 9. Disparities in tobacco marketing and product availability at the point of sale: Results of a national study.
    Ribisl KM; D'Angelo H; Feld AL; Schleicher NC; Golden SD; Luke DA; Henriksen L
    Prev Med; 2017 Dec; 105():381-388. PubMed ID: 28392252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IQOS Marketing in the US: The Need to Study the Impact of FDA Modified Exposure Authorization, Marketing Distribution Channels, and Potential Targeting of Consumers.
    Berg CJ; Abroms LC; Levine H; Romm KF; Khayat A; Wysota CN; Duan Z; Bar-Zeev Y
    Int J Environ Res Public Health; 2021 Oct; 18(19):. PubMed ID: 34639851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heated tobacco products likely appeal to adolescents and young adults.
    McKelvey K; Popova L; Kim M; Chaffee BW; Vijayaraghavan M; Ling P; Halpern-Felsher B
    Tob Control; 2018 Nov; 27(Suppl 1):s41-s47. PubMed ID: 30352843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid-response surveillance of the first US test market for VLN cigarettes.
    Henriksen L; Johnson TO; Mahoney M; Schleicher NC; Ali A; Prochaska JJ
    Tob Control; 2024 Jun; 33(4):549-552. PubMed ID: 36927515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Price Promotions of E-Liquid Products Sold in Online Stores.
    Ma S; Jiang S; Ling M; Chen J; Shang C
    Int J Environ Res Public Health; 2022 Jul; 19(14):. PubMed ID: 35886722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FDA's reduced exposure marketing order for IQOS: why it is not a reliable global model.
    Lempert LK; Bialous S; Glantz S
    Tob Control; 2022 Aug; 31(e1):e83-e87. PubMed ID: 33811155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticipating IQOS market expansion in the United States.
    Abroms L; Levine H; Romm K; Wysota C; Broniatowski D; Bar-Zeev Y; Berg C
    Tob Prev Cessat; 2022; 8():04. PubMed ID: 35174298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An Analysis of E-Cigarette Marketing in New Zealand Tobacco Retail Outlets Prior to Legislative Change.
    Bateman J; Robertson LA; Marsh L; Cameron C; Hoek J
    Nicotine Tob Res; 2020 Jun; 22(7):1221-1224. PubMed ID: 31811294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Content analysis of IQOS direct mail and email marketing in the US.
    Henderson KC; Kute NG; Popova L; Ashley DL; Spears CA; Churchill V; Weaver SR; Pechacek TF; Huang J
    Prev Med Rep; 2024 Feb; 38():102634. PubMed ID: 38375169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted advertising, promotion, and price for menthol cigarettes in California high school neighborhoods.
    Henriksen L; Schleicher NC; Dauphinee AL; Fortmann SP
    Nicotine Tob Res; 2012 Jan; 14(1):116-21. PubMed ID: 21705460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disparities in retail marketing for menthol cigarettes in the United States, 2015.
    Mills SD; Henriksen L; Golden SD; Kurtzman R; Kong AY; Queen TL; Ribisl KM
    Health Place; 2018 Sep; 53():62-70. PubMed ID: 30055469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sales Trends in Price-Discounted Cigarettes, Large Cigars, Little Cigars, and Cigarillos-United States, 2011-2016.
    Wang TW; Falvey K; Gammon DG; Loomis BR; Kuiper NM; Rogers T; King BA
    Nicotine Tob Res; 2018 Sep; 20(11):1401-1406. PubMed ID: 29253226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.